The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased ... Although the ...
The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
The FDA has approved the first generic liraglutide indicated to improve glycemic control in adults and pediatric patients ...
The Food and Drug Administration approved Eli Lilly ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...
It should be used with a reduced-calorie diet and ... the new FDA green light doesn’t expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically ...
The agency issued its decision on Friday, giving the stamp of approval for Zepbound's use among adults with obesity for use in combination with a reduced-calorie diet ... FDA's Center for Drug ...
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...